Command Palette

Search for a command to run...

Clinical Trials · NCT00566813

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

CompletedPhase 1/Phase 2Exenatide (Approved)
Phase
Phase 1/Phase 2
Recruitment status
Completed
Sponsor
University of Illinois at Chicago
Enrollment
10
Start date
Nov 2004
Locations
1 site, United States
Primary endpoint
Number of Participants With Adverse Events Including Laboratory Abnormalities at the End of Study Participation
View Exenatide compound reference